Prognostic impact of VEGF and VEGF receptor 1 (FLT1) expression in patients irradiated for stage II/III non-small cell lung cancer (NSCLC).

Dirk Rades; Cornelia Setter; Juergen Dunst; Olav Dahl; Steven E Schild; Frank Noack

doi:10.1007/s00066-010-2131-4

Prognostic impact of VEGF and VEGF receptor 1 (FLT1) expression in patients irradiated for stage II/III non-small cell lung cancer (NSCLC).

Dirk Rades, Cornelia Setter, Juergen Dunst, Olav Dahl, Steven E Schild, Frank Noack

Abstract

The prognostic value of the tumor expression of vascular endothelial growth factor (VEGF) and VEGF receptor 1 (FLT1) is still unclear. This study investigated the impact of tumor expression of VEGF and FLT1 on outcomes in 61 patients irradiated for stage II/III non-small cell lung cancer (NSCLC).

Original language	English
Title of host publication	Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]
Number of pages	8
Publication date	06.2010
Pages	307-14
ISBN (Print)	0006601021314
DOIs	https://doi.org/10.1007/s00066-010-2131-4
Publication status	Published - 06.2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00066-010-2131-4

Cite this

Rades, D., Setter, C., Dunst, J., Dahl, O., Schild, S. E., & Noack, F. (2010). Prognostic impact of VEGF and VEGF receptor 1 (FLT1) expression in patients irradiated for stage II/III non-small cell lung cancer (NSCLC). In Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] (pp. 307-14). (Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]; Vol. 186). https://doi.org/10.1007/s00066-010-2131-4

Rades, Dirk ; Setter, Cornelia ; Dunst, Juergen et al. / Prognostic impact of VEGF and VEGF receptor 1 (FLT1) expression in patients irradiated for stage II/III non-small cell lung cancer (NSCLC). Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]. 2010. pp. 307-14 (Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]).

@inbook{ee14d49da1a0492db7ed54a212fe8c9b,

title = "Prognostic impact of VEGF and VEGF receptor 1 (FLT1) expression in patients irradiated for stage II/III non-small cell lung cancer (NSCLC).",

abstract = "The prognostic value of the tumor expression of vascular endothelial growth factor (VEGF) and VEGF receptor 1 (FLT1) is still unclear. This study investigated the impact of tumor expression of VEGF and FLT1 on outcomes in 61 patients irradiated for stage II/III non-small cell lung cancer (NSCLC).",

author = "Dirk Rades and Cornelia Setter and Juergen Dunst and Olav Dahl and Schild, {Steven E} and Frank Noack",

year = "2010",

month = jun,

doi = "10.1007/s00066-010-2131-4",

language = "English",

isbn = "0006601021314",

series = "Strahlentherapie und Onkologie : Organ der Deutschen R{\"o}ntgengesellschaft ... [et al]",

pages = "307--14",

booktitle = "Strahlentherapie und Onkologie : Organ der Deutschen R{\"o}ntgengesellschaft ... [et al]",

}

Rades, D, Setter, C, Dunst, J, Dahl, O, Schild, SE & Noack, F 2010, Prognostic impact of VEGF and VEGF receptor 1 (FLT1) expression in patients irradiated for stage II/III non-small cell lung cancer (NSCLC). in Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]. Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al], vol. 186, pp. 307-14. https://doi.org/10.1007/s00066-010-2131-4

Prognostic impact of VEGF and VEGF receptor 1 (FLT1) expression in patients irradiated for stage II/III non-small cell lung cancer (NSCLC). / Rades, Dirk; Setter, Cornelia; Dunst, Juergen et al.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]. 2010. p. 307-14 (Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]; Vol. 186).

Research output: Chapters in Books/Reports/Conference Proceedings › Chapter › peer-review

TY - CHAP

T1 - Prognostic impact of VEGF and VEGF receptor 1 (FLT1) expression in patients irradiated for stage II/III non-small cell lung cancer (NSCLC).

AU - Rades, Dirk

AU - Setter, Cornelia

AU - Dunst, Juergen

AU - Dahl, Olav

AU - Schild, Steven E

AU - Noack, Frank

PY - 2010/6

Y1 - 2010/6

N2 - The prognostic value of the tumor expression of vascular endothelial growth factor (VEGF) and VEGF receptor 1 (FLT1) is still unclear. This study investigated the impact of tumor expression of VEGF and FLT1 on outcomes in 61 patients irradiated for stage II/III non-small cell lung cancer (NSCLC).

AB - The prognostic value of the tumor expression of vascular endothelial growth factor (VEGF) and VEGF receptor 1 (FLT1) is still unclear. This study investigated the impact of tumor expression of VEGF and FLT1 on outcomes in 61 patients irradiated for stage II/III non-small cell lung cancer (NSCLC).

U2 - 10.1007/s00066-010-2131-4

DO - 10.1007/s00066-010-2131-4

M3 - Chapter

C2 - 20437013

SN - 0006601021314

T3 - Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]

SP - 307

EP - 314

BT - Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]

ER -

Rades D, Setter C, Dunst J, Dahl O, Schild SE, Noack F. Prognostic impact of VEGF and VEGF receptor 1 (FLT1) expression in patients irradiated for stage II/III non-small cell lung cancer (NSCLC). In Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]. 2010. p. 307-14. (Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]). doi: 10.1007/s00066-010-2131-4